标题
The impact of treatment of hepatitis C with DAAs on the occurrence of HCC
作者
关键词
-
出版物
LIVER INTERNATIONAL
Volume 38, Issue -, Pages 139-145
出版商
Wiley
发表日期
2018-02-10
DOI
10.1111/liv.13659
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis
- (2017) Sujan Ravi et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Clinical Practice Update—Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection
- (2017) Ira M. Jacobson et al. GASTROENTEROLOGY
- Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
- (2017) Pierre Nahon et al. GASTROENTEROLOGY
- Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
- (2017) Fasiha Kanwal et al. GASTROENTEROLOGY
- Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrence
- (2017) Maria Francesca Donato et al. JOURNAL OF HEPATOLOGY
- Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
- (2017) Jose Luis Calleja et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
- (2017) Reem Waziry et al. JOURNAL OF HEPATOLOGY
- Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatiti
- (2017) H. Toyoda et al. JOURNAL OF VIRAL HEPATITIS
- Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals
- (2017) Alberto Zanetto et al. LIVER TRANSPLANTATION
- Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?
- (2017) Loreto Boix et al. SEMINARS IN LIVER DISEASE
- Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection
- (2016) Hashem B. El-Serag et al. HEPATOLOGY
- Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution
- (2016) Jean-Charles Nault et al. JOURNAL OF HEPATOLOGY
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
- (2016) Fabio Conti et al. JOURNAL OF HEPATOLOGY
- The impact of direct-acting antivirals on early tumor recurrence after radiofrequency ablation in hepatitis C-related hepatocellular carcinoma
- (2016) Tatsuya Minami et al. JOURNAL OF HEPATOLOGY
- Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma
- (2016) Ju Dong Yang et al. JOURNAL OF HEPATOLOGY
- High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
- (2016) Helder Cardoso et al. JOURNAL OF HEPATOLOGY
- Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment
- (2016) Karin Kozbial et al. JOURNAL OF HEPATOLOGY
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Graham R. Foster et al. JOURNAL OF HEPATOLOGY
- Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Michelle C.M. Cheung et al. JOURNAL OF HEPATOLOGY
- Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts
- (2016) JOURNAL OF HEPATOLOGY
- Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection
- (2016) Masahiro Kobayashi et al. JOURNAL OF MEDICAL VIROLOGY
- Effect of HCV clearance with direct-acting antiviral agents on HCC
- (2016) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response
- (2015) Bryony Simmons et al. CLINICAL INFECTIOUS DISEASES
- Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function
- (2015) Elisavet Serti et al. GASTROENTEROLOGY
- Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes
- (2015) Hamish A. Innes et al. HEPATOLOGY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
- (2014) Jean–Michel Pawlotsky GASTROENTEROLOGY
- Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
- (2014) Yujin Hoshida et al. JOURNAL OF HEPATOLOGY
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
- (2013) Rebecca L. Morgan et al. ANNALS OF INTERNAL MEDICINE
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study
- (2012) Eiichi Ogawa et al. JOURNAL OF HEPATOLOGY
- Outcome of sustained virological responders with histologically advanced chronic hepatitis C
- (2010) Timothy R. Morgan et al. HEPATOLOGY
- Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
- (2009) Savino Bruno et al. HEPATOLOGY
- Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
- (2008) Anna S. Lok et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More